InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by ROBIN SHERRINGTON, Directeur Exécutif. Director active across 2 companies, notably Xenon Pharmaceuticals Inc.. In total, 3 disclosures have been published. The latest transaction was filed on 4 March 2022 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations3 total
€4,0921,234 shares@ €3.31620.0001% mcap5.1% of flow
Common Shares
SEC:0001209191-22-017318:0·
€38,06812,345 shares@ €3.0837100.0% of flow
Common Shares
SEC:0001209191-21-036802·
€38,06812,345 shares@ €3.08370.0007% mcap47.4% of flow
Common Shares
SEC:0001209191-21-036802:0·
3 of 3 declarations
About ROBIN SHERRINGTON
Robin Sherrington is Executive Vice President of Strategy and Innovation at Xenon Pharmaceuticals Inc. She is responsible for strategic leadership and innovation within the company, contributing to its development.
